Joe Pickrell, CEO - Jan 01, 2023

2022 Gencove year in review

Read More >

Maximillian Rozenblum, Applied Bioinformatics Engineer - Nov 10, 2022

New species: salmon

New pipeline available: salmon

Read More >

Zlatko Mašek - Nov 03, 2022

Importing samples from existing projects

Samples already on the Gencove platform can now be easily reprocessed using a different project configuration.

Read More >

Forest Dussault, Software Engineer - Nov 01, 2022

Processing deep sequencing data with the Gencove platform

To help move towards Gencove’s vision of ubiquitous sequencing, we’re happy to announce support for our deep whole genome sequencing (WGS) pipeline!

Read More >

David Neuman, Head of Plant and Animal Genomics Sales - Aug 25, 2022

A Genotyping Platform that Changes with Your Breeding Program

Invest in a genotyping solution that changes with your breeding program. The Gencove platform ensures backward compatibility, adaptability to new markers and reference genomes, additional analyses, and continual innovation.

Read More >

David Neuman, Head of Plant and Animal Genomics Sales - Aug 23, 2022

The Importance of Speed in Plant and Animal Breeding

Improve molecular breeding efficiency with a modern genotyping approach that can be set up in a few weeks plus turns your samples around quickly!

Read More >

Jesse Hoff, Agrigenomics Product Manager - Jul 06, 2022

Get the Utility of Sequencing at the Cost of a Microarray

Gencove’s low-pass sequencing platform is at cost-per-sample price parity with many microarray assays across a wide range of species in both plants and animals. That makes Gencove the best choice for getting the utility of sequencing data at microarray prices.

Read More >

Jesse Hoff, Agrigenomics Product Manager - Jun 15, 2022

A Modern Approach to Genotyping for Plant and Animal Breeding

There’s no question that sequencing is a powerhouse of utility for genetics in breeding. However, does it meet the requirements to become a routine tool for genomic selection in breeding programs?

Read More >

Josh Setton, Head of Sales - Jun 09, 2022

Three Ways Gencove’s Low-Pass Whole Genome Sequencing is Modernizing the Drug Discovery Process

Pharmaceutical companies use Whole Exome Sequencing (WES) in their drug discovery and development process. However, R&D teams still need a comprehensive view of genomic variation outside the exome. Historically, the only way to augment WES was with arrays, but now pharma companies have an alternative - low-pass whole genome sequencing.

Read More >

Jesse Hoff, Agrigenomics Product Manager - Jun 02, 2022

The First EPD for Bovine Congestive Heart Failure from Simplot and Gencove

The Simplot and Gencove genomic EPD provides a benchmark from which bulls can be evaluated for cardiac morphology significantly reducing their calves’ morbidity and mortality and increasing their overall economic performance.

Read More >

Kristi Ashton, Head of Marketing - Jun 01, 2022

Gencove and Element Biosciences, Inc., Reduce the Cost and Complexity of Obtaining Genomic Information

To offer another option for scientists and companies seeking whole genome sequencing and analysis, Gencove evaluated the ability to process low-pass sequencing data derived from the AVITI™ System in two studies.

Read More >

Jesse Hoff, Agrigenomics Product Manager - May 12, 2022

Introducing InfiniSEEK - Low-pass Genotyping Plus Target Capture in One Assay

Whether it is genotyping a whole herd or building support for new species and breeds, at Gencove, we’re continually looking for ways to empower companies and scientists to discover more using sequencing. That’s why we’re excited to share the latest milestone in this pursuit with the launch of InfiniSEEK™– available now through NEOGEN.

Read More >